PI3K/Akt signaling pathway
The Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB) pathway carries signals from cell-surface receptors to the machinery controlling growth, survival, metabolism, motility and angiogenesis, and is among the most frequently dysregulated pathways in human disease.
The Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB) pathway carries signals from cell-surface receptors to the machinery controlling growth, survival, metabolism, motility and angiogenesis, and is among the most frequently dysregulated pathways in human disease. Growth factors and cytokines acting through receptor tyrosine kinases recruit class I phosphoinositide 3-kinase, a lipid kinase built from a regulatory subunit and one of four catalytic subunits — p110α, p110β, p110δ and p110γ, encoded by PIK3CA, PIK3CB, PIK3CD and PIK3CG, whose distinct tissue distributions matter for which isoform a drug should hit. The activated enzyme phosphorylates PIP2 to PIP3, a membrane lipid that recruits AKT through its PH domain; PDK1 and mTORC2 then phosphorylate AKT at two sites to activate it fully. Active AKT phosphorylates Mtor, FOXO transcription factors, GSK-3β and the pro-apoptotic protein BAD, promoting protein synthesis and cell-cycle progression while suppressing the apoptotic program — which is why caspase-3 activation falls when the pathway is on and rises when it is blocked. The tumor suppressor PTEN removes the 3-phosphate from PIP3 and is the pathway's principal brake; its loss leaves AKT constitutively active.
Constitutive activation is accordingly a hallmark of many cancers, including lung adenocarcinoma, hepatocellular carcinoma, oral squamous cell carcinoma, breast cancer, glioma and multiple myeloma, where it supports epithelial–mesenchymal transition, metastasis, and resistance to agents such as cisplatin, gemcitabine and bortezomib. It intersects with cell-death programs beyond apoptosis, including ferroptosis, and with redox and inflammatory biology through reactive oxygen species handling, toll-like receptor signaling and NF-κB. It also runs alongside the RAS/MAPK, JAK-STAT and HIF-1α axes, and reciprocal relief of feedback between those cascades is the usual reason single-agent inhibition disappoints — one of several arguments for combination targeting.
Because the same pathway transmits insulin's metabolic signal, inhibiting it produces hyperglycemia as a mechanism-based class effect, which has constrained dosing throughout its development. Clinical progress has come from narrowing the target: isoform-selective PI3K inhibitors matched to a mutation, AKT inhibitors, and Mtor inhibitors such as everolimus, rather than pan-PI3K blockade. Inhibition is not always the goal — in wound healing, stem cell–based nerve repair, and mesenchymal stem cell or exosome-delivered growth factor therapies, PI3K/AKT activation is what is wanted. Upstream receptor tyrosine kinase inhibitors such as gefitinib reduce flux through the pathway indirectly, and natural products reported to modulate it, among them berberine and naringenin, remain a large preclinical literature whose in vivo relevance is mostly unsettled.
Where the papers sit
22 papers from the last 6 months study PI3K/Akt signaling pathway directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 1 human data · 19 preclinical · 2 unclassified
Themes 4 themes · 2 new directions
-
Inflammation and Tissue Repair
PI3K/AKT modulation is being directed toward reducing inflammatory injury while improving tissue repair. Recurring settings include skin and diabetic wounds, intestinal radiation damage, infection, asthma, microglial inflammation and neurovascular regeneration. Exosomes, stem cells, hydrogels and botanical formulations are being paired with pathway regulation, often alongside changes in TNF, IL-6, autophagy or oxidative stress. Most evidence remains preclinical, and the balance between pathway activation for repair and inhibition for inflammation is context-dependent.
10 papers · 45.5%
-
PI3K/AKT Cancer Progression
PI3K/AKT inhibition is being used to curb proliferation, invasion, metastasis and radioresistance across several cancers. Natural compounds such as leonurine, scutellarein and alantolactone recur alongside gefitinib and pathway combinations involving ERK or MAPK. Anti-PD-L1 delivery is moving the work toward combined pathway and immune therapy. The evidence remains predominantly cellular or preclinical, with cancer-specific mechanisms still differing.
7 papers · 31.8%
-
Vascular Remodeling and Angiogenesis
Vascular remodeling is the shared focus, linking angiogenesis, vasodilation and microvascular adaptation to PI3K/Akt signaling. Shoutai Wan is associated with an ERβ-ANGPT2 axis in decidual vessels, while Da chuanxiong formula engages PI3K/Akt/eNOS. The work favors improving vascular function rather than simply suppressing vessel growth. Lung adenocarcinoma studies add gene-based risk and functional validation, leaving the clinical significance of the vascular link unresolved.
3 papers · 13.6%
-
Insulin Resistance and Glucose Uptake
Restoring insulin-stimulated glucose uptake is the central aim, with GLUT4 trafficking as the recurring endpoint. Luteolin and evodiamine are being examined as natural compounds that reactivate the IRS-1/PI3K/AKT/GLUT4 axis. Evidence relies on biochemical pathway assays, western blotting and glucose-uptake measurements. Whether these effects translate into durable treatment for type 2 diabetes remains open.
2 papers · 9.1%
PI3K/Akt signaling is implicated in ferroptosis-linked drug sensitization in multiple myeloma
The multiple-myeloma study of MYBL2 found that knocking down MYBL2 promotes ferroptosis and increases bortezomib sensitivity through a CDKN3 interaction with PI3K/Akt signaling 42345518Jun. Whereas the other papers use PI3K/Akt mainly to explain proliferation, apoptosis, inflammation, metabolism, angiogenesis, or tissue repair, this paper assigns the pathway a distinct role in regulating iron-dependent cell death and treatment response. The result extends the pathway’s relevance from conventional survival and growth phenotypes to ferroptotic vulnerability as a mechanism of chemosensitization.
PI3K/Akt signaling is positioned as a regulator of autophagy during herpes simplex encephalitis
The herpes simplex encephalitis study of urolithin A in HSV-1-infected microglia 42931954Oct assigns PI3K/Akt signaling a role outside the set’s recurring categories of inflammatory injury, cancer progression, metabolism, angiogenesis, and tissue regeneration by connecting it to autophagy control in infected microglia. Urolithin A reduced inflammatory polarization and excessive autophagy, with rescue experiments implicating PI3K/Akt signaling and changes in LC3-II/LC3-I and p62. This makes autophagy regulation, rather than inflammation alone, a distinct functional endpoint through which the pathway operates.
Papers
The 22 papers from the last 6 months that study PI3K/Akt signaling pathway directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Inflammation and Tissue Repair (10)
- ZhiXie capsule mitigates ionizing radiation-induced intestinal injury by inhibiting PI3K/AKT signaling pathway. Journal of molecular histology · 6 Nov 2026 PMID 42993329
- Analysis of Urolithin A's regulation of microglial inflammation and autophagy in herpes simplex encephalitis via modulating the PI3K/AKT signaling pathway through network pharmacology. Experimental brain research · 26 Oct 2026 PMID 42931954
- An Integrated Strategy for Decoding Bioactive Components and Mechanism of Jingtong Granules: Chemical Characterization, Network Analysis, Pharmacokinetic and Pharmacodynamic Studies. Biomedical chromatography : BMC · 17 Sept 2026 PMID 42750651
- TET2 promotes monocyte inflammatory activation in asthma via ALKBH5-m6A regulation and PI3K signaling: evidence from m6A-SNP and single-cell analyses. Molecular genetics and genomics : MGG · 9 Sept 2026 PMID 42714648
- Hierarchically Aligned HNTs-Based Composite Foam with Immunomodulatory Activity for Diabetic Wound Healing. ACS applied bio materials · 17 Aug 2026 PMID 42606047
- Wireless Magnetoelectric Stimulation Platform Orchestrating Multicellular Coupling in Complex Neurovascularized Tissue Regeneration. ACS nano · 20 Jul 2026 PMID 42473233
- ADSC-Exo-bFGF promotes skin wound healing and correlates with the PI3K/AKT signaling pathway activation. Journal of molecular histology · 16 Jul 2026 PMID 42461467
- Yinhuapinggan granules regulate PI3K/AKT and RAS/MAPK pathways to inhibit Streptococcus Pneumoniae-induced inflammatory responses. Archives of microbiology · 9 Jul 2026 PMID 42423763
- MYBL2 Knockdown Enhances Ferroptosis and Bortezomib Sensitivity by Transcriptionally Regulating CDKN3 and Inactivating PI3K/Akt Signaling in Multiple Myeloma. Journal of biochemical and molecular toxicology · 25 Jun 2026 PMID 42345518
- CeO2-Loaded Shear-Thinning Hydrogel Combined with Dental Pulp Stem Cells Modulates the Oxidative-Inflammatory Microenvironment To Enhance Facial Nerve Regeneration. ACS applied materials & interfaces · 25 Jun 2026 PMID 42343878
PI3K/AKT Cancer Progression (7)
- Alantolactone inhibits T-cell lymphoma progression by suppressing CD47 expression via the PI3K/AKT and ERK signaling pathways. Apoptosis : an international journal on programmed cell death · 23 Aug 2026 PMID 42634031
- COX7A2L drives lung adenocarcinoma progression and radioresistance via PI3K/AKT signaling. Life sciences · 27 Jul 2026 PMID 42508754
- Agomelatine versus gefitinib against HepG2 cells: Modulating PI3K/AKT and MAPK/RAF1/c-FOS pathways. Molecular biology reports · 16 Jul 2026 PMID 42461339
- Leonurine inhibits the proliferation and metastasis of liver cancer cells by regulating the PI3K/AKT signaling pathway via epithelial‑mesenchymal transition. Molecular medicine reports · 10 Jul 2026 PMID 42429151
- Astragalus polysaccharide-based thermoresponsive hydrogel loaded with β-elemene nanoemulsion in combination with anti-PD-L1 therapy for triple-negative breast cancer. International journal of biological macromolecules · 8 Jul 2026 PMID 42419545
- Scutellarein Induces Apoptosis in SCC-25 Oral Squamous Cell Carcinoma Cells Through Suppression of the PI3K/Akt Pathway. Anticancer research · 27 May 2026 PMID 42203337
- THBS1: a biomarker for PCOS and its role in pathogenesis via the PI3K/AKT signaling pathway. Mammalian genome : official journal of the International Mammalian Genome Society · 21 May 2026 PMID 42165848
Vascular Remodeling and Angiogenesis (3)
- Mechanism of Shoutai Wan against recurrent spontaneous abortion: regulation of decidual vascular remodeling via ERβ-ANGPT2 signaling axis. Functional & integrative genomics · 11 Sept 2026 PMID 42726298
- Da chuanxiong formula improves vascular remodeling via promoting angiogenesis and vasodilation mediated by PI3K/Akt/eNOS signaling. Metabolic brain disease · 3 Sept 2026 PMID 42690475
- Glycosylation-related gene risk model and functional validation of OSTC and TUBA1C in lung adenocarcinoma. Respiratory research · 17 Jul 2026 PMID 42464299
Insulin Resistance and Glucose Uptake (2)
- Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
- Luteolin from Lonicera japonica Thunb. restores GLUT4-mediated glucose uptake via PI3K/Akt signaling in insulin resistance. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 13 Jun 2026 PMID 42287758
By study type
Human data, design not indexed (1)
- TET2 promotes monocyte inflammatory activation in asthma via ALKBH5-m6A regulation and PI3K signaling: evidence from m6A-SNP and single-cell analyses. Molecular genetics and genomics : MGG · 9 Sept 2026 PMID 42714648
Preclinical: animal, cell and lab studies (19)
- ZhiXie capsule mitigates ionizing radiation-induced intestinal injury by inhibiting PI3K/AKT signaling pathway. Journal of molecular histology · 6 Nov 2026 PMID 42993329
- Analysis of Urolithin A's regulation of microglial inflammation and autophagy in herpes simplex encephalitis via modulating the PI3K/AKT signaling pathway through network pharmacology. Experimental brain research · 26 Oct 2026 PMID 42931954
- An Integrated Strategy for Decoding Bioactive Components and Mechanism of Jingtong Granules: Chemical Characterization, Network Analysis, Pharmacokinetic and Pharmacodynamic Studies. Biomedical chromatography : BMC · 17 Sept 2026 PMID 42750651
- Mechanism of Shoutai Wan against recurrent spontaneous abortion: regulation of decidual vascular remodeling via ERβ-ANGPT2 signaling axis. Functional & integrative genomics · 11 Sept 2026 PMID 42726298
- Da chuanxiong formula improves vascular remodeling via promoting angiogenesis and vasodilation mediated by PI3K/Akt/eNOS signaling. Metabolic brain disease · 3 Sept 2026 PMID 42690475
- Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
- Alantolactone inhibits T-cell lymphoma progression by suppressing CD47 expression via the PI3K/AKT and ERK signaling pathways. Apoptosis : an international journal on programmed cell death · 23 Aug 2026 PMID 42634031
- Hierarchically Aligned HNTs-Based Composite Foam with Immunomodulatory Activity for Diabetic Wound Healing. ACS applied bio materials · 17 Aug 2026 PMID 42606047
- Wireless Magnetoelectric Stimulation Platform Orchestrating Multicellular Coupling in Complex Neurovascularized Tissue Regeneration. ACS nano · 20 Jul 2026 PMID 42473233
- ADSC-Exo-bFGF promotes skin wound healing and correlates with the PI3K/AKT signaling pathway activation. Journal of molecular histology · 16 Jul 2026 PMID 42461467
- Agomelatine versus gefitinib against HepG2 cells: Modulating PI3K/AKT and MAPK/RAF1/c-FOS pathways. Molecular biology reports · 16 Jul 2026 PMID 42461339
- Leonurine inhibits the proliferation and metastasis of liver cancer cells by regulating the PI3K/AKT signaling pathway via epithelial‑mesenchymal transition. Molecular medicine reports · 10 Jul 2026 PMID 42429151
- Yinhuapinggan granules regulate PI3K/AKT and RAS/MAPK pathways to inhibit Streptococcus Pneumoniae-induced inflammatory responses. Archives of microbiology · 9 Jul 2026 PMID 42423763
- Astragalus polysaccharide-based thermoresponsive hydrogel loaded with β-elemene nanoemulsion in combination with anti-PD-L1 therapy for triple-negative breast cancer. International journal of biological macromolecules · 8 Jul 2026 PMID 42419545
- MYBL2 Knockdown Enhances Ferroptosis and Bortezomib Sensitivity by Transcriptionally Regulating CDKN3 and Inactivating PI3K/Akt Signaling in Multiple Myeloma. Journal of biochemical and molecular toxicology · 25 Jun 2026 PMID 42345518
- CeO2-Loaded Shear-Thinning Hydrogel Combined with Dental Pulp Stem Cells Modulates the Oxidative-Inflammatory Microenvironment To Enhance Facial Nerve Regeneration. ACS applied materials & interfaces · 25 Jun 2026 PMID 42343878
- Luteolin from Lonicera japonica Thunb. restores GLUT4-mediated glucose uptake via PI3K/Akt signaling in insulin resistance. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 13 Jun 2026 PMID 42287758
- Scutellarein Induces Apoptosis in SCC-25 Oral Squamous Cell Carcinoma Cells Through Suppression of the PI3K/Akt Pathway. Anticancer research · 27 May 2026 PMID 42203337
- THBS1: a biomarker for PCOS and its role in pathogenesis via the PI3K/AKT signaling pathway. Mammalian genome : official journal of the International Mammalian Genome Society · 21 May 2026 PMID 42165848
Unclassified: not yet indexed with MeSH (2)
- COX7A2L drives lung adenocarcinoma progression and radioresistance via PI3K/AKT signaling. Life sciences · 27 Jul 2026 PMID 42508754
- Glycosylation-related gene risk model and functional validation of OSTC and TUBA1C in lung adenocarcinoma. Respiratory research · 17 Jul 2026 PMID 42464299
Written from 22 PubMed abstracts, each one listed by PMID above. Published: 2026-06-16. Last written: 2026-09-11 by GPT. Corrections: 2026-08-08 by GPT. Reviewed by a human editor on 2026-07-23. Drafted by language models from published abstracts; not medical advice.